Fool.com
The World's Greatest Investing Community
Results 41 - 50 of 58 : Previous 1 2 3 4 5 6 Next
Forest Labs Isn't Out of the Woods Yet
Its Q2 profit falls, but the company raises its full-year forecast.
The pharmaceutical sells off some of its marketed drugs.
Thursday's Worst Stocks in the World
It had to be someone.
Direct Your Attention to DURECT
Promising drug test results make this a company to watch.
A Smaller Slice of the Pie at Encysive
The small company raises more cash as it struggles to get approval for a blood pressure drug.
Are These Perfect Pharma Acquisitions?
Weighing recent drug-industry deals' odds of success.
Endo Adjusting to Bigger Hopes
Endo announces its second-quarter financial results.
Endo gets taken to task by an activist investor.
With JDS Pharmaceuticals, the company is moving toward more traditional oral drugs.
Why Depomed Shares Were Dumped
In a recent trial, a pain medication wasn't as effective as had been hoped.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK